Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B

Journal of Viral Hepatitis

Volumn 18, Issue 7, 2011, Pages

  Sanai, F M ^a,f   Helmy, A ^b   Bzeizi, K I ^c   Babatin, M A ^d   Al Qahtani, A ^b,f   Al Ashgar, H A ^b   Al Mdani, A S ^c   Al Akwaa, A ^e   Almutharea, S ^d   Khan, M Q ^b   Alghamdi, A S ^d   Farah, T ^d   Al Hamoudi, W ^f   Saadeh, M ^g   Abdo, A A ^f  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^d KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^e King Abdul Aziz Hospital   (Saudi Arabia)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

^g KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER   (Saudi Arabia)

Author keywords

alanine aminotransferase; biopsy; chronic hepatitis B; fibrosis; HBV DNA; histology; necroinflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERLIPIDEMIA; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; VIREMIA;

EID: 79959578090     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01437.x     Document Type: Article

References (22)

1. El-Hazmi MA,. Hepatitis B in Saudi Arabia. J Trop Med Hyg 1989; 92 (1): 56-61.
2. Funk ML, Rosenberg DM, Lok ASF,. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002; 9: 52-61. (Pubitemid 36002487)
3. Martinot-Peignoux M, Boyer N, Colombat M, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002; 36: 543-546. (Pubitemid 34407344)
4. Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK,. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. J Viral Hepat 2008; 15: 434-441. (Pubitemid 351677546)
5. Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ,. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2007; 46: 1057-1070. (Pubitemid 350147802)
6. Chandra R, Kapoor D, Agarwal SR, Malhotra V, Sakhuja P, Sarin SK,. Profile of asymptomatic chronic HBV infection in India. Indian J Med Res 2002; 116: 50-57. (Pubitemid 36131237)
7. Wang CC, Lim LY, Deubner H, et al. Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT. J Clin Gastroenterol 2008; 42: 820-826.
8. Nguyen MH, Garcia RT, Trinh HN, et al. Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels. Am J Gastroenterol 2009; 104: 2206-2213.
9. Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-1384. (Pubitemid 351615375)
10. Papatheodoridis GV, Manesis EK, Manolakopoulos S, et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology 2008; 48: 1451-1459.
11. El-Zayadi AR, Badran HM, Saied A, Shawky S, Attia Mel-D, Zalata K,. Evaluation of liver biopsy in EgyptianHBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy. Am J Gastroenterol 2009; 104: 906-911.
12. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009; 50: 227-242.
13. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A,. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001; 80: 63-71. (Pubitemid 35333911)
14. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.
15. Kleiner DE, Brunt EM, Van Natta M, et al.; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 1313-1321. (Pubitemid 40770284)
16. Lok AS, McMahon BJ,. Chronic hepatitis B: update 2009. Hepatology 2009; 50 (3): 1-36. DOI.
17. Tsang PS, Trinh H, Garcia RT, et al. Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol. 2008; 6: 569-574. (Pubitemid 351609458)
18. Park JY, Park YN, Kim DY, et al. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels. J Viral Hepat 2008; 15: 615-621.
19. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ,; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006; 130: 678-686. (Pubitemid 43374518)
20. Minakari M, Molaei M, Shalmani HM, et al. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors. Eur J Gastroenterol Hepatol 2009; 21: 512-516.
21. Yun JW, Cho YK, Park JH, et al. Hepatic steatosis and fibrosis in young men with treatment-naîve chronic hepatitis B. Liver Int 2009; 29: 878-883.
22. Shi JP, Fan JG, Wu R, et al. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J Gastroenterol Hepatol 2008; 23: 1419-1425.